Fundraising Fox

Jan Møller Mikkelsen

InvestorFounder

President at Ascendis Pharma A/S · Founder, President and Chief Executive Officer at Ascendis Pharma

San Francisco Bay Area

Writes $10M – $50M checks · typically $25M

FoundedAscendis Pharma

Find your path to Jan

51 people in our graph share verified history with Jan — schools, employers, funds. One of them is your warm intro.

Jesper GromadaunlockedJan: together at Novo Nordisk (1995–1999)
×2Jan: together at Maxygen, Inc.
Jan: together at Ascendis Pharma A/S
×8Jan: together at Novo Nordisk

About

Jan Møller Mikkelsen is President and Chief Executive Officer of Ascendis Pharma A/S, which he founded in 2007. The biopharmaceutical company develops therapies using its TransCon technology platform, with a pipeline including three endocrinology rare disease candidates in clinical development and an oncology program. Ascendis has achieved positive Phase 3 results for TransCon hGH and is preparing a Biologics License Application submission.

Founder, President and Chief Executive Officer at Ascendis Pharma

Intro paths

In turn, Jan can intro founders to Ascendis Pharma's investors below.

Experience

  1. Ascendis Pharma A/SPresident and Chief Executive Officercurrent2007 — present
  2. LifeCycle Pharma A/SPresident and Chief Executive Officer2002 — 2006Denmark
  3. Maxygen, Inc.President, Protein Pharmaceutical Division2000 — 2002Denmark and Redwood City, CA
  4. ProFound A/SCo-Founder and co-Chief Executive Officer1999 — 2000Denmark
  5. Novo NordiskVice President, Protein Discovery1991 — 1999Denmark
  6. Novo NordiskManager, Enzyme Structure1989 — 1991Denmark
  7. Nordisk GentofteResearch Scientist1987 — 1989Denmark

Colleagues at Ascendis Pharma A/S

Network1

Investors connected to Jan in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jan Møller Mikkelsen?
Jan Møller Mikkelsen is President and Chief Executive Officer of Ascendis Pharma A/S, which he founded in 2007. The biopharmaceutical company develops therapies using its TransCon technology platform, with a pipeline including three endocrinology rare disease candidates in clinical development and an oncology program. Ascendis has achieved positive Phase 3 results for TransCon hGH and is preparing a Biologics License Application submission.
Where does Jan Møller Mikkelsen work?
Jan Møller Mikkelsen is Founder, President and Chief Executive Officer of Ascendis Pharma and President at Ascendis Pharma A/S.
What check size does Jan Møller Mikkelsen write?
Jan Møller Mikkelsen typically writes checks of $10M – $50M.
What companies did Jan Møller Mikkelsen found?
Jan Møller Mikkelsen founded Ascendis Pharma.
Where did Jan Møller Mikkelsen go to school?
Jan Møller Mikkelsen studied at Odense University (Cand. Scient., Biochemistry); Children’s Hospital Oakland (Post-doctoral research, Biochemistry).

Founder mafias

Shared employers